Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

MeVis Medical Solutions (0HI7) Share Price & Analysis

0HI7 Stock Chart & Stats

€22.00€0.00(0.00%)
At close: 4:30 PM GMT
€22€22.5€23€23.528 Jul7 Sep29 Sep8 Oct
Day’s Range
EUR 22.00 - EUR 22.00
52-Week Range
EUR 21.80 - EUR 26.40
Previous Close
EUR 22.00
Volume
0
Average Volume (3M)
0
Market Cap
EUR 37.13M
Enterprise Value
EUR 39.30T
Total Cash (Recent Filing)
EUR 3.65M
Total Debt (Recent Filing)
EUR 0
Price to Earnings (P/E)
26.8
Beta
-0.06
Next Earnings
Jan 28, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
4.68%

Bulls Say, Bears Say

Bulls Say

Debt-free Balance Sheet

A debt-free structure gives MeVis greater resilience through operating weakness because no interest burden or refinancing schedule competes for cash. Stable equity also preserves flexibility to fund product development, shareholder returns, or strategic investment without relying on additional borrowing.

Strong Profitability

Persistently high gross margins and healthy operating profitability indicate that the software model retains meaningful economic value after development and delivery costs. This margin structure can support reinvestment and cash generation, even though recent earnings have fallen from earlier peak levels.

Solid Cash Profitability

Free cash flow that usually tracks reported net income provides evidence that earnings are generally supported by cash rather than being purely accounting-driven. That supports ongoing funding capacity and gives the company a durable base for operations and capital allocation over coming quarters.

Bears Say

Persistent Revenue Decline

Three consecutive annual revenue declines point to a sustained weakening in demand, market reach, or customer expansion rather than a single-period fluctuation. Continued top-line contraction can reduce operating leverage, limit reinvestment capacity, and make future earnings growth harder to restore.

Lower Profitability Than Peak

The sharp reduction in net margin shows that the company is converting less revenue into earnings than it did at its 2022 peak. If this lower profitability persists, it could constrain internal funding, reduce return potential, and weaken the financial benefit of the otherwise attractive software margin model.

Uneven Cash-flow Conversion

Wide variation in operating cash conversion means reported earnings do not translate into cash consistently from year to year. That variability makes financial planning less predictable and can limit confidence in the timing of internally funded investment, distributions, or other capital allocation decisions.

0HI7 FAQ

What was MeVis Medical Solutions’s price range in the past 12 months?
MeVis Medical Solutions lowest share price was €21.80 and its highest was €26.40 in the past 12 months.
What is MeVis Medical Solutions’s market cap?
MeVis Medical Solutions’s market cap is €37.13M.
When is MeVis Medical Solutions’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MeVis Medical Solutions’s earnings last quarter?
MeVis Medical Solutions released its earnings results on May 21, 2026. The company reported €0.342 earnings per share for the quarter.
Is MeVis Medical Solutions overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does MeVis Medical Solutions pay dividends?
MeVis Medical Solutions does not currently pay dividends.
What is MeVis Medical Solutions’s EPS estimate?
MeVis Medical Solutions’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MeVis Medical Solutions have?
MeVis Medical Solutions has 1,820,000 shares outstanding.
What happened to MeVis Medical Solutions’s price movement after its last earnings report?
MeVis Medical Solutions reported an EPS of €0.342 in its last earnings report. Following the earnings report the stock price went down -2.586%.
Which hedge fund is a major shareholder of MeVis Medical Solutions?
Currently, no hedge funds are holding shares in GB:0HI7
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology